Insider Trading activities at Sigilon Therapeutics, Inc. (SGTX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sigilon Therapeutics, Inc. (SGTX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sigilon Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1821323.

Total stock buying since 2020: $31,039,915.
Total stock sales since 2020: $2,000,000.
Total stock option exercises since 2020: $189,628.


6 insiders reported insider trading activities at Sigilon Therapeutics, Inc. (SGTX):
Insider trading activities of Eli Lilly & Co
Insider trading activities of Shenandoah Acquisition Corp
Insider trading activities of Vivaldi Coelho Rogerio
Insider trading activities of Anderson Daniel Griffith
Insider trading activities of Pontes Josias
Insider trading activities of Yuan Qing Sarah

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Sigilon Therapeutics, Inc. (SGTX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2023 1,718,493 $25,639,915 0 $0 9,856 $189,628
2021 0 $0 200,000 $2,000,000 0 $0
2020 300,000 $5,400,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Sigilon Therapeutics, Inc. (SGTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2023-08 1,718,493 $25,639,915 0 $0 0 $0
2023-07 0 $0 0 $0 9,856 $189,628
2021-06 0 $0 200,000 $2,000,000 0 $0
2020-12 300,000 $5,400,000 0 $0 0 $0

Table 3. Detailed insider trading at Sigilon Therapeutics, Inc. (SGTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2023-08-11 Shenandoah Acquisition Corp (10% Owner) Buy 1,718,493 14.92 25,639,915
2023-07-27 Yuan Qing Sarah (CTOO) Option Ex 2,884 19.24 55,488
2023-07-21 Pontes Josias (CHIEF FINANCIAL OFFICER) Option Ex 1,444 19.24 27,782
2023-07-21 Vivaldi Coelho Rogerio (PRESIDENT AND CEO) Option Ex 5,528 19.24 106,358
2021-06-02 Anderson Daniel Griffith Sale 200,000 10.00 2,000,000
2020-12-08 Eli Lilly & Co Buy 300,000 18.00 5,400,000

Insider trading activities including stock purchases, stock sales, and option exercises of SGTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sigilon Therapeutics, Inc. (symbol SGTX, CIK number 1821323) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.